NCT06060613
Safety and Efficacy of OBX-115 in Advanced Solid Tumors treatment 1 / 2 recruiting NCT06343402
Study of BBO-8520 in Adult Subjects with KRASG12C Non-small Cell Lung and Colorectal Cancer treatment 1 recruiting NCT06625775
Dose Escalation and Expansion of BBO-10203 in Advanced Solid Tumors (BREAKER-101) treatment 1 recruiting NCT03177291
Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC treatment 1 active_not_recruiting NCT05609578
Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation treatment 2 recruiting NCT05786924
A Study of BDTX-4933 in Patients With KRAS, BRAF and Select RAS/MAPK Mutation-Positive Cancers No drug interventions treatment 1 active_not_recruiting NCT05846594
A Study to Evaluate the Impact of Liquid Biopsy in Participants With a Clinical Diagnosis of Advanced Cancer No drug interventions diagnostic 4 active_not_recruiting NCT06622174
Pulse Radiotherapy to Overcome Metastatic Immune System Evasion in Lung Cancer No drug interventions treatment 1 not_yet_recruiting NCT05241873
(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations treatment 1 / 2 active_not_recruiting NCT04708483
DCE-CT of Thoracic Tumors as an Early Biomarker for Treatment Monitoring in Comparison With Morphologic Criteria No drug interventions diagnostic Not Available unknown_status NCT00986661
A Study to Assess PV-10 Chemoablation of Cancer of the Liver treatment 1 active_not_recruiting NCT05408871
Non-invasive Measurement of PD-L1 Levels With Positron Emission Tomography (PET) in Head and Neck Malignancies and Intracranial Metastases No drug interventions diagnostic 1 terminated NCT06032052
Single-drug Chemotherapy Plus Immunotherapy in Metastatic Non-small Cell Lung Cancer Elderly Patients No drug interventions treatment 2 recruiting NCT03867175
Immunotherapy With or Without SBRT in Patients With Stage IV Non-small Cell Lung Cancer treatment 3 active_not_recruiting NCT05143970
A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors treatment 1 recruiting NCT05502913
Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer treatment 2 recruiting NCT06481813
Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer Patients No drug interventions basic_science Not Available not_yet_recruiting NCT04161157
Piloting Pathways With Lung Cancer Patients No drug interventions supportive_care Not Available completed NCT03044626
Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLC treatment 2 completed NCT03721120
Evaluation of the Feasibility and Clinical Relevance of Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer No drug interventions diagnostic Not Available completed NCT03073473
Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers No drug interventions Not Available Not Available terminated NCT06180460
CALM: Managing Distress in Malignant Brain Cancer No drug interventions supportive_care Not Available recruiting NCT03514329
Vapor Ablation for Localized Cancer Lesions No drug interventions treatment Not Available not_yet_recruiting NCT01307501
Safety and Efficacy of Cryoablation for Metastatic Lung Tumors No drug interventions treatment Not Available completed NCT03198468
Vapor Ablation for Localized Cancer Lesions of the Lung (VAPORIZE) No drug interventions treatment Not Available completed NCT03345810
Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION) treatment 2 completed NCT05256290
Phase 1/2 Study of BDTX-1535 in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations No drug interventions treatment 1 / 2 recruiting NCT02310464
Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects treatment 1 completed NCT04804137
Immune Response Under Immunotherapy in Metastatic NSCLC: Sputum, Blood Samples and Microbioata Study No drug interventions Not Available Not Available completed NCT05908799
Emulation of the KEYNOTE-189 Trial Using Electronic Health Records Not Available Not Available completed NCT06165419
Definitive Radiation for High-Risk Spine Metastases No drug interventions treatment 2 recruiting NCT02109016
A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations treatment 2 terminated NCT06513663
Exercise as Maintenance Therapy in Advanced Lung Cancer No drug interventions supportive_care Not Available not_yet_recruiting NCT03143322
Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases No drug interventions treatment Not Available recruiting NCT04940325
Datopotamab (DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer treatment 2 recruiting NCT02640326
McMaster Catheterization for Thoracoscopic Surgery Study No drug interventions supportive_care Not Available withdrawn NCT03415126
A Study of ASN007 in Patients With Advanced Solid Tumors No drug interventions treatment 1 completed NCT04790682
LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNG No drug interventions diagnostic Not Available recruiting NCT05933876
The Impact of Radiotherapy on Oligometastatic Cancer No drug interventions Not Available Not Available recruiting NCT05544240
Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors No drug interventions treatment 1 recruiting NCT02469701
Advanced Non-Small Cell Lung Cancer Progressing After at Least One Prior Therapy For Metastatic Disease treatment 2 terminated NCT01543672
Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously No drug interventions treatment 1 / 2 completed NCT05703555
INTRUSION: Unraveling the INTRatUmoral PK/PD relatION for SAR408701 treatment 2 withdrawn NCT01814150
The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel No drug interventions Not Available Not Available unknown_status NCT04964960
Pembro+Chemo in Brain Mets treatment 2 terminated NCT06538012
TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer treatment 1 / 2 recruiting NCT05078047
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO No drug interventions treatment 3 recruiting NCT06228326
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs No drug interventions treatment 1 recruiting NCT06546839
SPSIPB vs SAPB for Thoracoscopic Surgery No drug interventions treatment Not Available recruiting NCT03755102
A Pilot Study of Dacomitinib With or Without Osimertinib for Patients With Metastatic EGFR Mutant Lung Cancers With Disease Progression on Osimertinib. treatment 0 completed NCT05452005
Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer No drug interventions diagnostic 1 recruiting NCT05706883
Clinical and Molecular Findings in Patients With Cervical/Supraclavicular Metastasis From Non-small-cell Lung Cancer (NSCLC) No drug interventions Not Available Not Available completed NCT03272971
Feasibility Study of the RF Ablation Catheter to Ablate Lung Tumors No drug interventions device_feasibility Not Available terminated NCT04440800
Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer Treatment No drug interventions Not Available Not Available unknown_status NCT04973436
DBT for Metastatic Lung Cancer No drug interventions treatment Not Available completed NCT03595813
Identifying Immune-related Biomarkers to Predict the Efficacy of Cancer Immunotherapy No drug interventions basic_science Not Available active_not_recruiting NCT03703596
Anlotinib Versus Docetaxel as the Second-line Treatment in EGFR Wild Type Patients With Advanced NSCLC treatment 2 unknown_status NCT05860296
Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers treatment 1 / 2 recruiting NCT06555263
Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer treatment 2 recruiting NCT03400748
ANET Electrosurgery Applicator Pilot Evaluation Study No drug interventions device_feasibility Not Available terminated NCT03693326
PDR001 in Patients With Non-small Cell Lung Cancer Harboring KRAS/NRAS Mutation or no Actionable Genetic Abnormalities treatment 2 unknown_status NCT03638765
Dendritic Cell Therapy for Brain Metastases From Breast- or Lung Cancer No drug interventions treatment 1 unknown_status NCT02308865
Early Palliative Care in Metastatic Lung Cancer in Northern France No drug interventions supportive_care Not Available terminated NCT05419076
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain No drug interventions treatment 2 recruiting NCT04311762
Phase 1 Trial of Endobronchial Ultrasound-Guided Transbronchial Needle Injection of Cisplatin for Stage IV Lung Cancer treatment 1 unknown_status NCT02976740
SBRT Combination With rhGM-CSF and Tα1 for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy No drug interventions treatment 2 unknown_status NCT06547710
Primary Tumor Resection for M1a Stage Lung Cancer No drug interventions Not Available Not Available recruiting NCT03970564
Neck Ultrasound by Respiratory Physicians in Patients With Lung Cancer No drug interventions Not Available Not Available completed NCT03076164
A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib treatment 1 / 2 completed NCT03706287
Efficacy and Safety of Anlotinib Plus Platinum Plus Pemetrexed in T790M-negative NSCLC treatment 1 / 2 unknown_status NCT03113851
Abscopal Effect of Radiation in Combination With rhGM-CSF for Metastatic Non-small Cell Lung Cancer treatment 2 completed NCT03344861
Safety of PDT-Photofrin® Prior to Lung Surgery other 1 completed NCT03184571
Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced NSCLC treatment 2 completed NCT04085315
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer treatment 1 recruiting NCT04986670
NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung Cancer No drug interventions supportive_care Not Available active_not_recruiting NCT03057106
Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC treatment 2 active_not_recruiting NCT03543306
Dabrafenib and Trametinib in Patients With Non-small Cell Lung Cancer Harboring V600E BRAF Mutation treatment 2 unknown_status NCT04069936
Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs™ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLC treatment 2 terminated NCT03439696
Needlescopic-assisted Uniportal vs Uniportal VATS No drug interventions treatment Not Available completed NCT03693339
Capmatinib in Patients With Non-small Cell Lung Cancer Harboring cMET exon14 Skipping Mutation treatment 2 unknown_status NCT05537922
I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy No drug interventions Not Available Not Available recruiting NCT06060262
The Alterations of Metabolic Adipo-myokines and Body Composition in End Stage Lung Cancer No drug interventions Not Available Not Available recruiting NCT05144529
A Randomized Pilot Study of Evolocumab Plus Nivolumab/Ipilimumab in Treatment-Naïve Patients With Metastatic NSCLC treatment 2 recruiting NCT04405401
Stereotactic Ablative Radiotherapy for Oligo-Progressive Non Small Cell Lung Cancer No drug interventions treatment 2 recruiting NCT06262555
Novel Light Delivery Method for Performing Transbronchial Photodynamic Therapy for Peripheral Lung Cancer No drug interventions treatment Not Available recruiting NCT03179150
Clinical Validation of the M5L Lung CAD No drug interventions Not Available Not Available completed NCT03242993
[18F]-AZAFOL AS POSITRON EMISSION TOMOGRAPHY (PET) TRACER in FR Positive Cancer Imaging diagnostic 1 completed